MERCK $47.80

down -0.15


17/6/2013 04:17 PM  |  NYSE : MRK  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 47.80
Trade Time: Jun 17 4:08 PM Eastern Daylight Time
Change: -0.15 (-0.31 %)
Prev Close: 47.95
Open: 48.33
Bid: 47.78
Ask: 47.80
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get MRK Trend Analysis - it has outperformed the S&P 500 by 0%

ETF Alternatives



People viewing MRK also viewed: , , , ,

Competitors

Ticker Name Volume % Change
CHHL CHINA HOLDINGS 1.0K +1.50%
GTHR GENETHERA 11.1K +1.29%
CKGT CHINA KANGTAI CACTUS BIO 71.5K +0.79%
COBI COMPASS BIOTECHNOLOGIES 10.0K +0.50%
ARYX ARYX THERAPEUTICS 325.0K +0.45%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/15/2013 AMBROSE ADELE D Sr.V-P & Chief Comuns Officer -34,208 $46.66 -71.24%
5/15/2013 AMBROSE ADELE D Sr.V-P & Chief Comuns Officer 14,000 $23.45 41.16%
5/15/2013 AMBROSE ADELE D Sr.V-P & Chief Comuns Officer 19,208 $33.49 129.71%
5/13/2013 Heller Bridgette P Exe.VP & Pres.Con.Hlth.Care -5,404 $46.15 -19.93%
5/7/2013 FRAZIER KENNETH C Chairman, President & CEO -16,133 $44.98 -5.86%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (MRK), click here.
View All

MRK Stock Analysis

  1. Luminex Collaborates with NMTC - Analyst Blog

    (LMNX,HTWR,BABY,MRK )
    Luminex has entered into a multi-year collaboration and license agreement with leading pharmacogenomic testing company Natural Molecular Testing Corporation.
  2.

    After A Good Run, Novartis Looks Fairly Valued

    (NVS,RHHBY,BMY,MRK,BIIB )
    Novartis is a well-balanced, high-quality pharma with growth credentials, but also a fair valuation today.

  3. Roche, Reloaded

    (RHHBY,BMY,GILD,MRK,JNJ )
    Roche has one of the best long-term growth profiles in the Big Pharma space
  4.

    After A Big Rally, Pfizer Might Need Some Rest

    (PFE,BMY,MRK,RHHBY )
    A big rally has brought Pfizer back to fair value.
  5.

    Amgen Chased By The Bubble

    (AMGN,PFE,SNY,TEVA,CELG,NVO,MRK,HSP,ABT,AFFY,BIIB,GILD )
    Amgen really needs the pipeline to come through to support this valuation.

  6. The “Healthy” Play In Contract Research Organizations

    (CVD,ICLR,PXRL,AMRI,MRK,CRL,CG,JPM,BMY,PFE )
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane clinical trial and lab work. This outsourcing will be a big win for the contract research organizations.
Free Reports
  1.

    3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
  2.

    21-page Book on Learning to Trade Options on Futures!

    Not too complex. Not too basic. Just enough information to help you ask the right questions so you can start using these markets.
  3.

    Forbes Wolfe Nanotech Report Nanotech 101

    Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!
Marketplace
Trading Center